ANTI ENDOMYSIAL ANTIBODY IGA - IFA (WITH TITER)

The Anti-Endomysial Antibody (EMA) IgA Test by Indirect Immunofluorescence Assay (IFA) with Titer is a highly specific blood test used to detect Immunoglobulin A (IgA) antibodies directed against the endomysium, the connective tissue surrounding smooth muscle fibers. These antibodies are strongly associated with celiac disease, an autoimmune disorder triggered by gluten consumption.

The test uses Indirect Immunofluorescence Assay (IFA) to identify Anti-Endomysial IgA antibodies and includes an antibody titer, which measures the concentration of antibodies in the blood. This information helps physicians assess the likelihood of celiac disease and monitor antibody levels when clinically indicated. The EMA IgA test is considered one of the most specific laboratory tests for diagnosing celiac disease.

Benefits of the Test

• Highly specific for diagnosing celiac disease.
• Detects Anti-Endomysial IgA antibodies using IFA.
• Includes antibody titer measurement for additional clinical information.
• Supports early diagnosis of gluten-related autoimmune disorders.
• Helps evaluate chronic gastrointestinal symptoms.
• Assists physicians in planning further investigations and treatment.

Why Doctors Recommend This Test

Doctors may recommend the Anti-Endomysial Antibody IgA (IFA with Titer) Test for individuals with symptoms or risk factors suggestive of celiac disease, including:

• Chronic diarrhea
• Abdominal pain and bloating
• Unexplained weight loss
• Iron deficiency anemia
• Chronic fatigue
• Nutrient malabsorption
• Delayed growth in children
• Family history of celiac disease
• Associated autoimmune disorders such as type 1 diabetes or autoimmune thyroid disease

The test is frequently used along with Tissue Transglutaminase (tTG) IgA, Total Serum IgA, and, when necessary, intestinal biopsy to confirm the diagnosis.

Preparation Before Test

• No fasting is required.
• Continue eating a normal gluten-containing diet before testing unless instructed otherwise by your physician.
• Inform your healthcare provider about medications and any diagnosed IgA deficiency.
• A blood sample is collected for laboratory analysis.

Normal Reporting Time

Reporting Time: Usually 3–7 working days, depending on laboratory processing protocols.

Who Should Take This Test?

This test is recommended for:

• Individuals with symptoms suggestive of celiac disease.
• Patients with chronic diarrhea or malabsorption.
• Individuals with unexplained anemia.
• Patients with a family history of celiac disease.
• Children with poor growth or unexplained gastrointestinal symptoms.
• Individuals undergoing evaluation for gluten-related autoimmune disorders.

Patient-Friendly Summary

The Anti-Endomysial Antibody IgA (IFA with Titer) Test is a blood test that helps diagnose celiac disease by detecting antibodies produced when the immune system reacts to gluten. In people with celiac disease, these antibodies attack the lining of the small intestine, leading to poor nutrient absorption and digestive problems. The test uses a highly accurate laboratory method called Indirect Immunofluorescence Assay (IFA) and also measures the antibody titer, which indicates the level of antibodies present in the blood. This test is especially valuable for confirming celiac disease when symptoms such as chronic diarrhea, bloating, weight loss, or anemia are present. It is a safe blood test that does not require fasting, but patients should continue eating gluten unless instructed otherwise by their doctor.